Metropolitan Life Insurance Company (MetLife)’s Harvard Bioscience HBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-2,337
| Closed | -$9.91K | – | 916 |
|
|
2024
Q1 | $9.91K | Buy |
2,337
+182
| +8% | +$772 | ﹤0.01% | 2134 |
|
|
2023
Q4 | $11.5K | Hold |
2,155
| – | – | ﹤0.01% | 2135 |
|
|
2023
Q3 | $9.27K | Hold |
2,155
| – | – | ﹤0.01% | 2241 |
|
|
2023
Q2 | $11.8K | Buy |
+2,155
| New | +$11.8K | ﹤0.01% | 2214 |
|
|
2022
Q2 | – | Sell |
-2,766
| Closed | -$17.2K | – | 2395 |
|
|
2022
Q1 | $17.2K | Sell |
2,766
-8,628
| -76% | -$53.6K | ﹤0.01% | 2155 |
|
|
2021
Q4 | $80.3K | Buy |
11,394
+178
| +2% | +$1.26K | ﹤0.01% | 2589 |
|
|
2021
Q3 | $78.3K | Buy |
+11,216
| New | +$78.3K | ﹤0.01% | 2650 |
|